Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -5.68% is 127% below its 5-year average of 20.74%, near the low end of its 5-year range (-5.68%–26.51%).
As of the fiscal period ended Saturday, April 4, 2026. 140.47% below its 12-month average of 14.04%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-5.68%
NET PROFIT MARGIN AVG TTM
14.04%
NET PROFIT MARGIN AVG 3Y
20.94%
NET PROFIT MARGIN AVG 5Y
22.13%
NET PROFIT MARGIN AVG 10Y
23.15%
NET PROFIT MARGIN AVG 15Y
22.91%
NET PROFIT MARGIN AVG 20Y
22.23%
CURRENT VS TTM AVG
-140.47%
CURRENT VS 3Y AVG
-127.14%
CURRENT VS 5Y AVG
-125.68%
CURRENT VS 10Y AVG
-124.55%
CURRENT VS 15Y AVG
-124.81%
CURRENT VS 20Y AVG
-125.57%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-154.43%
vs the sector median at left
Waters Corporation
Market Cap
$24.42B
Net Profit Margin
-5.68%
TTM Avg
14.04%
3Y Avg
20.94%
5Y Avg
22.13%
Market Cap
$24.34B
Net Profit Margin
6.66%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$25.15B
Net Profit Margin
12.02%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$23.51B
Net Profit Margin
26.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$23.10B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$22.43B
Net Profit Margin
40.61%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$26.82B
Net Profit Margin
21.40%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
Market Cap
$21.45B
Net Profit Margin
-143.55%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $24.42B | -5.68% | 14.04% | 20.94% | 22.13% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 6.66% | 6.01% | 6.56% | 9.24% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 12.02% | 8.91% | 9.15% | 11.71% |
| Incyte Corporation (INCY)vs › | $23.51B | 26.71% | 12.90% | 13.00% | 12.11% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 16.98% | 16.55% | 18.38% | 18.84% |
| BioNTech SE (BNTX)vs › | $22.59B | -44.73% | -31.89% | 3.77% | 12.08% |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 40.61% | 41.73% | 40.84% | 37.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 21.40% | 21.94% | 21.74% | 21.20% |
| Moderna, Inc. (MRNA)vs › | $21.45B | -143.55% | -128.24% | -70.25% | -50.87% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 7.54% | 10.12% | 9.68% | 22.03% |
Operating Margin
28.2%
Net Profit Margin
-5.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-04-04 | -5.68% |
| 2025-12-31 | 24.16% |
| 2025-09-27 | 18.62% |
| 2025-06-28 | 19.07% |
| 2025-03-29 | 18.34% |
| 2024-12-31 | 26.51% |
| 2024-09-28 | 21.82% |
| 2024-06-29 | 20.15% |
| 2024-03-30 | 16.05% |
| 2023-12-31 | 26.38% |
| 2023-09-30 | 18.91% |
| 2023-07-01 | 20.33% |
| 2023-04-01 | 20.58% |
| 2022-12-31 | 26.45% |
| 2022-10-01 | 22.02% |
| 2022-07-02 | 23.08% |
| 2022-04-02 | 23.14% |
| 2021-12-31 | 25.85% |
| 2021-10-02 | 24.45% |
| 2021-07-03 | 24.54% |
| 2021-04-03 | 24.34% |
| 2020-12-31 | 27.75% |
| 2020-09-26 | 21.35% |
| 2020-06-27 | 23.64% |
| 2020-03-28 | 11.52% |
| 2019-12-31 | 28.01% |
| 2019-09-28 | 23.93% |
| 2019-06-29 | 24.10% |
| 2019-03-30 | 21.21% |
| 2018-12-31 | 25.89% |
| 2018-09-29 | 24.40% |
| 2018-06-30 | 26.11% |
| 2018-03-31 | 21.10% |
| 2017-12-31 | -51.39% |
| 2017-09-30 | 24.06% |
| 2017-07-01 | 23.61% |
| 2017-04-01 | 21.20% |
| 2016-12-31 | 27.73% |
| 2016-10-01 | 23.70% |
| 2016-07-02 | 23.90% |
| 2016-04-02 | 19.79% |
| 2015-12-31 | 25.75% |
| 2015-10-03 | 23.23% |
| 2015-07-04 | 21.36% |
| 2015-04-04 | 20.86% |
| 2014-12-31 | 25.91% |
| 2014-09-27 | 23.01% |
| 2014-06-28 | 20.04% |
| 2014-03-29 | 16.33% |
| 2013-12-31 | 25.04% |
| 2013-09-28 | 21.44% |
| 2013-06-29 | 19.80% |
| 2013-03-30 | 28.13% |
| 2012-12-31 | 33.72% |
| 2012-09-29 | 22.03% |
| 2012-06-30 | 21.65% |
| 2012-03-31 | 21.09% |
| 2011-12-31 | 26.30% |
| 2011-10-01 | 22.28% |
| 2011-07-02 | 22.36% |
| 2011-04-02 | 22.10% |
| 2010-12-31 | 26.18% |
| 2010-10-02 | 23.62% |
| 2010-07-03 | 21.72% |
| 2010-04-03 | 20.54% |
| 2009-12-31 | 24.28% |
| 2009-10-03 | 20.31% |
| 2009-07-04 | 19.27% |
| 2009-04-04 | 22.02% |
| 2008-12-31 | 23.75% |
| 2008-09-27 | 18.51% |
| 2008-06-28 | 20.85% |
| 2008-03-29 | 18.42% |
| 2007-12-31 | 22.64% |
| 2007-09-29 | 15.11% |
| 2007-06-30 | 16.99% |
| 2007-03-31 | 16.91% |
| 2006-12-31 | 20.65% |
| 2006-09-30 | 16.73% |
| 2006-07-01 | 15.83% |
| 2006-04-01 | 15.21% |
| 2005-12-31 | 22.75% |
| 2005-10-01 | 9.42% |
| 2005-07-02 | 18.99% |
| 2005-04-02 | 17.37% |
| 2004-12-31 | 22.06% |
| 2004-10-02 | 19.61% |
| 2004-07-03 | 22.94% |
| 2004-04-03 | 16.01% |
| 2003-12-31 | 21.23% |
| 2003-09-30 | 15.81% |
| 2003-06-30 | 18.17% |
| 2003-03-31 | 15.37% |
| 2002-12-31 | 15.70% |
| 2002-09-30 | 18.06% |
| 2002-06-30 | 17.45% |
